Welcome to our dedicated page for HEXO news (Ticker: HEXO), a resource for investors and traders seeking the latest updates and insights on HEXO stock.
HEXO Corp., formerly known as Hydropothecary, is a leading licensed producer and distributor of medical marijuana under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Dedicated to medical excellence, HEXO excels in advanced cultivation techniques, stringent process controls, quality assurance testing, ongoing research and development, and exceptional customer service.
With a focus on expanding its operations, HEXO is set to add a significant 250,000 square feet greenhouse in 2018 to meet growing demand. The company is constantly seeking talented, energetic, and specialized professionals to join its dynamic team and contribute to the rapidly evolving cannabis industry.
HEXO's product portfolio includes a wide range of medical cannabis products designed to meet the diverse needs of patients. The company is committed to innovation and quality, ensuring that all products meet the highest standards of safety and efficacy.
In recent news, HEXO Corp. has announced key partnerships and strategic initiatives aimed at bolstering its market position and expanding its product offerings. These include collaborations with leading organizations and the introduction of new, innovative products that cater to both the medical and recreational cannabis markets.
Financially, HEXO has shown remarkable growth, reflecting its strong market presence and operational efficiency. The company continues to invest in infrastructure and technology to support its long-term growth strategy and maintain its competitive edge in the industry.
For more information on HEXO Corp.'s latest developments, financial performance, and upcoming projects, visit our news section for the most updated data and insights.
HEXO Corp (TSX: HEXO; NASDAQ: HEXO) announces the appointment of John K. Bell as Chair of the Board of Directors, effective December 14, 2021. This strategic move aims to enhance corporate governance as HEXO embarks on a new plan to solidify its leadership in the Canadian cannabis market. John brings over 40 years of experience in executive management, corporate governance, and financing, including a significant role at Canopy Growth. The company also expresses gratitude to Dr. Michael Munzar for his contributions during his tenure as Chair.
HEXO Corp (HEXO) announced it will release its financial results for the fiscal quarter ending October 31, 2021, on December 14, 2021, prior to market open. The company will also host a webcast for investors at 8:30 a.m. EST that day. HEXO, a licensed producer in the global cannabis market, serves the Canadian recreational market with various well-known brands and holds a significant share in the market following its acquisitions of Redecan and 48North. For more information, visit hexocorp.com.
HEXO Corp (TSX: HEXO; NASDAQ: HEXO) will participate in Cowen’s 4th Annual Cannabis Conference on November 30, 2021. Valerie Malone, Chief Commercial Officer, will be featured in the panel discussion, “Canadian Cannabis: The Adult Use Landscape,” scheduled for 10:10 a.m. ET. Additionally, HEXO management will be available for virtual one-on-one meetings with institutional clients. HEXO is a prominent licensed producer in the cannabis market, serving both recreational and medical sectors, and has recently expanded its market share with acquisitions of Redecan and 48North.
HEXO Corp announced the resignation of Sebastien St-Louis from its Board of Directors, effective immediately. President and CEO Scott Cooper has been appointed as his replacement. Dr. Michael Munzar, Chair of the Board, expressed gratitude for St-Louis's eight years of service, noting his role in establishing HEXO as a leader in the Canadian cannabis market. The company aims to leverage Cooper's extensive background in consumer packaged goods to enhance growth and profitability in advanced cannabis product commercialization.
HEXO Corp (HEXO) announced its strategy to centralize operations by decommissioning three production facilities acquired through recent mergers. The Kirkland Lake and Brantford facilities in Ontario will cease operations on January 31, 2022, while the Stellarton facility in Nova Scotia will close on February 28, 2022. This move aims to enhance efficiency and drive growth by focusing on core facilities, impacting approximately 155 employees. The integration is expected to strengthen HEXO's position in the Canadian cannabis market, where it holds a leading share.
HEXO Corp reported a strong performance in Q4’21, with total net revenue reaching $38.7 million, up from $22.6 million in Q3’21, marking a 71% growth quarter-over-quarter. For FY21, net revenue was $123.5 million, a 53% increase compared to $80.6 million in FY20. The company completed the acquisition of Zenabis Global and experienced significant growth in its cannabis beverage segment, achieving a 70% growth quarter-over-quarter. Despite strong sales, HEXO faces challenges such as increased operational expenses and a complex financial position regarding its senior secured convertible notes.
HEXO Corp (TSX: HEXO) is set to release its financial results for the fiscal quarter and year ending July 31, 2021, on October 29, 2021, before market hours. An investor webcast will follow at 8:30 a.m. ET. HEXO is a major player in the Canadian cannabis industry, boasting a diverse brand portfolio that includes HEXO, Redecan, and UP Cannabis. The company aims to strengthen its market position following recent acquisitions, indicating its commitment to innovation and growth in both recreational and medical cannabis sectors.
HEXO Corp has appointed Scott Cooper as the new President & CEO, effective immediately. Cooper previously led Truss Beverage Co., a cannabis beverage joint venture, and is expected to leverage his extensive experience in consumer goods to enhance HEXO's market position. Chairman Dr. Michael Munzar emphasized Cooper's qualifications in driving growth and profitability, especially following recent acquisitions. For six months, Cooper will also maintain his role at Truss to ensure a smooth transition. HEXO aims to solidify its status as a leading cannabis products company in Canada and globally.
HEXO Corp (TSX: HEXO; NASDAQ: HEXO) announced the immediate departure of CEO Sebastien St-Louis as part of a strategic reorganization. The company expresses gratitude for St-Louis's contributions to the Canadian cannabis industry and is currently seeking a new CEO through a Special Committee for Succession. Alongside this change, COO Donald Courtney will resign but remain until a replacement is found. HEXO aims to leverage recent acquisitions and maintain its market leader position in Canada's cannabis sector.
FAQ
What is the market cap of HEXO (HEXO)?
What does HEXO Corp. do?
What recent expansion projects has HEXO undertaken?
What kind of products does HEXO offer?
Has HEXO announced any new partnerships?
What is HEXO's financial outlook?
Where can I find more information about HEXO's latest news?
What regulatory framework does HEXO operate under?
Is HEXO involved in research and development?
What is HEXO's commitment to quality?
How does HEXO contribute to the cannabis industry?
